If you’ve been selling in May and planning to go away – as the old mistaken adage goes – I urge you to reverse course now while you still can.

If you’re selling this year, you’ll miss two major milestones for marijuana investors. And both are very bullish for some of my favorite stocks.

The first big milestone was hit today, as a matter of fact.

Another cannabis stock just started trading with the “big boys”: Organigram is now trading on the NASDAQ under the new ticker symbol “OGI.” It’s the very same opportunity I alerted you to on May 1. And it’s been on your radar even longer – if you’ve been following my Jumper Stock System.

This big move is a big deal. It gives the stock instant credibility, opens it up to more institutional dollars, and almost always results in more analyst coverage.

Organigram is now one of just 15 pot stocks available on the NASDAQ.

And like most of the others, it’s a Canadian company.

But compared to the other Canadian stocks – it’s still pretty cheap. In the most recent quarter, Organigram sold 5,000 kilograms (kg) of cannabis. That puts it in second place to Canopy Growth (CGC). And it’s nearly double what Aphria (APHA) sold – yet Aphria has a larger market cap!

This is a great example of why you’ve got to buy these stocks before they make the “jump.” And Organigram is just the beginning. That’s why I recommend it in my Early Stage Investor newsletter.

The other big milestone I wanted talk about is next Friday, May 31.

That’s when the U.S. Food & Drug Administration (FDA) will hold a public hearing on cannabidiol (CBD).

Sounds like a problem, right? Actually, it’s not.

This signals that the FDA is looking to set some ground rules for CBD products. Remember, the FDA isn’t just for “food & drugs.” It also deals with supplements and cosmetics. That covers basically all the possibilities for CBD.

So, the FDA can regulate CBD. The question is: How?

After next Friday, we’ll be able to make a more informed analysis. In these hearings, you want to pay special attention to the FDA’s opening remarks, as well as the speakers it gives the most “airtime” to – which is usually the earlier ones. That’s where we’ll find clues as to where the FDA is leaning: A) new regulations, B) new “guidance,” or C) application of existing laws.

Ultimately, this is all good news.

While I’m no big fan of regulations, in the long term, it’s going to be a positive for the CBD industry. The FDA is going to “weed out” all the dubious products and marketing. No one will be able to claim (for instance) that their CBD product will cure cancer when they don’t have the research to back it up. Without these “bad actors” in the way, legitimate CBD companies can rise to the top.

These are the products we can buy with confidence. And we’ll know exactly how much to take – just like we do with Epidiolex, the CBD-based seizure medication that won FDA approval last June.

This, in turn, gives investors more confidence in CBD companies – providing further upside for stocks like Charlotte’s Web (CWBHF).

Charlotte’s Web is my pick in InvestorPlace’s Best Stocks for 2019 contest. So I don’t mind telling you that it’s high on my list of potential Jumper Stocks.

And I alerted folks to another possible jumper in my recent presentation on the topic.

I see so much potential here that I’m giving away this pick for free at the end.

You can also get a play-by-play of my Jumper Stock System by clicking here now.

I expect marijuana stocks jumping to the major exchanges will be a huge catalyst for several more years as legalization expands and the industry continues to explode.

P.S. Our Jumper Stock System has already identified four other names that look extremely promising.

I expect all of them to jump to a major stock exchange within the next 12 months, which makes NOW the time to buy.

I still receive a lot of questions about investing in marijuana stocks in general, and I’ve also received some about my Jumper Stock System. I address the biggest questions and concerns you might have in a brand new Q&A video. I even walk through my Jumper Stock System step by step.

You can watch this special Q&A by clicking here. You’ll walk away with a deeper understanding of this incredible opportunity and how my system really works.

Plus, I reveal a special development my publisher has agreed to for anyone who wants to dip their toes in the water. (I honestly can’t believe he’s agreed to let me do this.)

Click here now to watch this short, informative Q&A.

Learn where Matt McCall sees
huge investment opportunities right now:

Autonomous Vehicles: A Once-in-a-Generation Opportunity

Self-driving cars – aka “autonomous vehicles” (AVs) – represent one of the biggest investment opportunities of the next 25 years. This innovation will transform huge portions of our economy and create trillion dollar ripple effects through time. It will create huge new winners in short periods of time. It will demolish losers in equally short periods of time. It’s critical that you stay on the right side of this trend. Learn more here.

Why the Legal Marijuana Industry is Set to Grow More than 10-Fold

Marijuana has been outlawed most everywhere for decades… but now a wave of legalization is starting to sweep the world. This will create massive new markets and massive stock market winners. Learn more here.

2019 Will Be Sports Betting’s Biggest Year Yet

If I had to make one bet for 2019 it would be that betting is going to be big. The Supreme Court’s May 14 ruling cleared the way for states to allow sports gambling. And in my 25 years of investing experience, I honestly cannot remember many things that come close to magnitude of the investing opportunity that opened up to us. Massive amounts of money are involved in sports betting, and I expect massive amounts of money will be made, too. Learn more here.